Year archive

NAVCO Pharmaceuticals — 2022 filings

All 15 regulatory filings released by NAVCO Pharmaceuticals (NAV) in 2022, sourced directly from the official regulator.

15 Filings

2022 Period

2022 filings (15)

Filing	Released	Lang
News release - English.pdf Regulatory Filings	2022-12-01	English
Other.pdf Capital/Financing Update	2022-12-01	English
Filing statement - English.pdf Regulatory Filings	2022-12-01	English
Other.pdf Regulatory Filings	2022-12-01	English
Other.pdf Regulatory Filings	2022-12-01	English
Interim financial statements/report – English.pdf Interim / Quarterly Report Q1 2023	2022-11-29	English
Interim MD&A - English.pdf Interim / Quarterly Report Q1 2023	2022-11-29	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2022-11-29	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2022-11-29	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2022-10-26	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2022-10-26	English
Annual MD&A - English.pdf Management Reports	2022-10-26	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf Regulatory Filings	2022-10-26	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf Regulatory Filings	2022-10-26	English
Audited annual financial statements – English.pdf Audit Report / Information FY 2022	2022-10-26	English